Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization
Само за регистроване кориснике
2019
Аутори
Mitrović, JelenaDivović, Branka
Dobričić, Vladimir
Čalija, Bojan
Vulić, Jelena P.
Knutson, Daniel E.
Cook, James M.
Savić, Miroslav
Savić, Snežana
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Deuterated pyrazoloquinolinones, GABAn receptor ligands, are being investigated for neuropsychiatric disorders treatment. Among others, DK-l-56-1 (7-Methoxy-2-(4-methoxy-d3- p h e n yl ) - 2, 5 -d i h yd ro - 3 H - py r azolo -14,3 -clq u i n o I i n - 3-one) was chosen as the lead component [1]. Because of its low solubility in water (6.27 t0.74 pg/ml) nanosuspension formulation for prospective parenteral administration was carried out [2]. ...
Извор:
10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria, 2019Напомена:
- BioNanoMed 2019
Институција/група
PharmacyTY - CONF AU - Mitrović, Jelena AU - Divović, Branka AU - Dobričić, Vladimir AU - Čalija, Bojan AU - Vulić, Jelena P. AU - Knutson, Daniel E. AU - Cook, James M. AU - Savić, Miroslav AU - Savić, Snežana PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5542 AB - Deuterated pyrazoloquinolinones, GABAn receptor ligands, are being investigated for neuropsychiatric disorders treatment. Among others, DK-l-56-1 (7-Methoxy-2-(4-methoxy-d3- p h e n yl ) - 2, 5 -d i h yd ro - 3 H - py r azolo -14,3 -clq u i n o I i n - 3-one) was chosen as the lead component [1]. Because of its low solubility in water (6.27 t0.74 pg/ml) nanosuspension formulation for prospective parenteral administration was carried out [2]. ... C3 - 10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria T1 - Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization UR - https://hdl.handle.net/21.15107/rcub_farfar_5542 ER -
@conference{ author = "Mitrović, Jelena and Divović, Branka and Dobričić, Vladimir and Čalija, Bojan and Vulić, Jelena P. and Knutson, Daniel E. and Cook, James M. and Savić, Miroslav and Savić, Snežana", year = "2019", abstract = "Deuterated pyrazoloquinolinones, GABAn receptor ligands, are being investigated for neuropsychiatric disorders treatment. Among others, DK-l-56-1 (7-Methoxy-2-(4-methoxy-d3- p h e n yl ) - 2, 5 -d i h yd ro - 3 H - py r azolo -14,3 -clq u i n o I i n - 3-one) was chosen as the lead component [1]. Because of its low solubility in water (6.27 t0.74 pg/ml) nanosuspension formulation for prospective parenteral administration was carried out [2]. ...", journal = "10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria", title = "Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization", url = "https://hdl.handle.net/21.15107/rcub_farfar_5542" }
Mitrović, J., Divović, B., Dobričić, V., Čalija, B., Vulić, J. P., Knutson, D. E., Cook, J. M., Savić, M.,& Savić, S.. (2019). Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization. in 10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria. https://hdl.handle.net/21.15107/rcub_farfar_5542
Mitrović J, Divović B, Dobričić V, Čalija B, Vulić JP, Knutson DE, Cook JM, Savić M, Savić S. Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization. in 10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria. 2019;. https://hdl.handle.net/21.15107/rcub_farfar_5542 .
Mitrović, Jelena, Divović, Branka, Dobričić, Vladimir, Čalija, Bojan, Vulić, Jelena P., Knutson, Daniel E., Cook, James M., Savić, Miroslav, Savić, Snežana, "Nanonization of new patent protected substances - carrier selection for preclinical research: physicochemical and in vivo behavioral characterization" in 10th International Congress Nanotechnology in Medicine & Biology, 15 - 17. April 2019, Graz / Austria (2019), https://hdl.handle.net/21.15107/rcub_farfar_5542 .